Page last updated: 2024-08-21

2-tert-butylhydroquinone and Bone Diseases, Metabolic

2-tert-butylhydroquinone has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hernández-Álvarez, D; Königsberg, M; Lopéz-Cervantes, SP; López-Diazguerrero, NE; Luna-López, A; Mena-Montes, B; Pedraza-Vázquez, G; Sánchez-Garibay, C; Toledo-Pérez, R1

Other Studies

1 other study(ies) available for 2-tert-butylhydroquinone and Bone Diseases, Metabolic

ArticleYear
Metformin and tBHQ Treatment Combined with an Exercise Regime Prevents Osteosarcopenic Obesity in Middle-Aged Wistar Female Rats.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Animals; Bone Diseases, Metabolic; Female; Hydroquinones; Metformin; Obesity; Physical Conditioning, Animal; Rats; Sarcopenia

2021